IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 122 filers reported holding IVERIC BIO INC in Q4 2020. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $77,530,682 | -21.6% | 1,970,785 | -51.5% | 0.03% | -23.8% |
| Q1 2023 | $98,950,962 | +9.2% | 4,067,035 | -3.9% | 0.04% | +2.4% |
| Q4 2022 | $90,605,343 | +113.9% | 4,231,917 | +79.2% | 0.04% | +95.2% |
| Q3 2022 | $42,358,000 | +4081.4% | 2,361,070 | +2142.2% | 0.02% | – |
| Q2 2022 | $1,013,000 | -41.4% | 105,300 | +2.4% | 0.00% | -100.0% |
| Q1 2022 | $1,730,000 | +0.9% | 102,800 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $1,714,000 | +2.9% | 102,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,665,000 | +205.5% | 102,500 | +18.8% | 0.00% | – |
| Q2 2021 | $545,000 | +26.7% | 86,300 | +24.2% | 0.00% | – |
| Q1 2021 | $430,000 | -17.5% | 69,500 | -7.8% | 0.00% | – |
| Q4 2020 | $521,000 | +22.6% | 75,400 | 0.0% | 0.00% | – |
| Q3 2020 | $425,000 | +10.4% | 75,400 | 0.0% | 0.00% | – |
| Q2 2020 | $385,000 | – | 75,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |